http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112021003492-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed93d603fa5bc691ce6925045742bdee |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1a68e682a8eaa66fb38917becbdacf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_717e1f5f4db7b971086f2094d789b023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b8a3383aefeba4b431ac20e869f445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45958e4d1b71652bfeda724dd48f9bea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64af48998b69efe1e4ba4e9d3f6325fe |
| publicationDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112021003492-A2 |
| titleOfInvention | Substituted 2,4-diaminoquinoline as a new drug for diseases related to fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) |
| abstract | “2,4-DIAMINOQUINOLINE REPLACED AS A NEW MEDICINE FOR DISEASES RELATED TO FIBROSIS, AUTOPHAGY AND CATHEPSIN B (CTSB), L (CTSL) AND D (CTSD)”. The present invention relates to new 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicines. The active compounds of the present invention may be useful as a medicine in the treatment and/or alleviation and/or prevention of fibrosis and/or fibrosis related diseases or for use as a medicine in the treatment and/or alleviation and/or or for the prevention of autophagy and/or autophagy-related diseases and for the inhibition of autophagic flow or for use in the inhibition of cathepsins B (CTSB), L (CTSL) and/or D (CTSD) and/or diseases related to cathepsins B (CTSB), L (CTSL) and/or D (CTSD); with the proviso that said compounds must not be used for the treatment of any forms of cancers. |
| priorityDate | 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2181.